SENDAI Protocol

Printer-friendly versionPDF version

SENDAI Protocol

 

A Phase I double-blind, randomized, placebo-controlled, dose-escalation trial to

evaluate the safety and immunogenicity of a Sendai HIV vaccine SeV-G(NP)

given intranasally and Ad35-GRIN administered intramuscularly in prime-boost

regimens in HIV-uninfected, healthy adult volunteers.

AttachmentSize
SENDAI Protocol.doc21.5 KB
SENDAI Protocol.docx12.9 KB
SENDAI Protocol.jpg44.62 KB
SENDAI Protocol.pdf4.45 KB
SENDAI Protocol.ppt1.58 MB

Contacts

KAVI Institute of Clinical Research (KAVI-ICR)

College of Health Sciences

University of Nairobi

P.O. Box 19676 - 00202

Nairobi,

Kenya.

 

Telephone: +254-20-2717694/2725404

 

Mobile: +254-722-207417

 

Fax: +254-20-2714613

 

E-mail: kavi@kaviuon.org

 

Locate us>>

Community Outreach

Media Center

UoN Website | UoN Repository | ICTC Website


Copyright © 2017. ICT WebTeam, University of Nairobi